Fletta eftir höfundi "Erlinge, David"

Atriði 1-2 af 2

Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial) : Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial

Malm, Carl Johan; Alfredsson, Joakim; Erlinge, David; Guðbjartsson, Tómas; Gunn, Jarmo; James, Stefan; Møller, Christian H; Nielsen, Susanne J; Sartipy, Ulrik; Tønnessen, Theis; Jeppsson, Anders (2023-05)

The TACSI trial (ClinicalTrials.gov Identifier: NCT03560310) tests the hypothesis that 1-year treatment with dual antiplatelet therapy with acetylsalicylic acid (ASA) and ticagrelor is superior to only ASA after isolated coronary artery bypass grafting ...
Instantaneous wave-free ratio compared with fractional flow reserve in PCI : A cost-minimization analysis

Berntorp, Karolina; Persson, Josefine; Koul, Sasha M.; Patel, Manesh R.; Christiansen, Evald H.; Guðmundsdóttir, Ingibjörg Jóna; Yndigegn, Troels; Omerovic, Elmir; Erlinge, David; Fröbert, Ole; Götberg, Matthias; Gudmundsdottir, Ingibjörg (2021-12-01)

Background: Coronary physiology is a routine diagnostic tool when assessing whether coronary revascularization is indicated. The iFR-SWEDEHEART trial demonstrated similar clinical outcomes when using instantaneous wave-free ratio (iFR) or fractional ...

Atriði 1-2 af 2

Leita